These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2319734)

  • 1. Severe type III hyperlipoproteinemia in two patients maintained on chronic hemodialysis.
    Feussner G; Bommer J; Ziegler R
    Klin Wochenschr; 1990 Jan; 68(2):65-70. PubMed ID: 2319734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type III hyperlipoproteinemia in a child with hemolytic uremic syndrome.
    Feussner G; Wingen AM; Ziegler R
    Metabolism; 1990 Nov; 39(11):1196-9. PubMed ID: 2233282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of type III hyperlipoproteinemia: analysis of 64 patients.
    Feussner G; Wagner A; Kohl B; Ziegler R
    Clin Investig; 1993 May; 71(5):362-6. PubMed ID: 8508005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E phenotypes in hyperlipidaemic patients and their implications for treatment.
    Janus ED; Grant S; Lintott CJ; Wardell MR
    Atherosclerosis; 1985 Nov; 57(2-3):249-66. PubMed ID: 3866582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of infusion of normal plasma on lipoproteins in type III hyperlipoproteinemia.
    Stuyt PM; Demacker PN; van 't Laar A
    Horm Metab Res; 1981 Dec; 13(12):715-6. PubMed ID: 7319472
    [No Abstract]   [Full Text] [Related]  

  • 6. A young type III hyperlipoproteinemic patient associated with apolipoprotein E deficiency.
    Mabuchi H; Itoh H; Takeda M; Kajinami K; Wakasugi T; Koizumi J; Takeda R; Asagami C
    Metabolism; 1989 Feb; 38(2):115-9. PubMed ID: 2492364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoproteins of special significance in atherosclerosis. Insights provided by studies of type III hyperlipoproteinemia.
    Mahley RW; Innerarity TL; Rall SC; Weisgraber KH
    Ann N Y Acad Sci; 1985; 454():209-21. PubMed ID: 3000263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-HDL-cholesterol/apolipoprotein B ratio: a useful distinguishing feature in the screening for type III hyperlipoproteinemia.
    Murase T; Okubo M; Takeuchi I
    J Clin Lipidol; 2010; 4(2):99-104. PubMed ID: 21122636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperapobetalipoproteinemia: the major dyslipoproteinemia in patients with chronic renal failure treated with chronic ambulatory peritoneal dialysis.
    Sniderman A; Cianflone K; Kwiterovich PO; Hutchinson T; Barre P; Prichard S
    Atherosclerosis; 1987 Jun; 65(3):257-64. PubMed ID: 3619989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [From gene to disease; apolipoprotein E2 and familial dysbetalipoproteinemia].
    Smelt AH
    Ned Tijdschr Geneeskd; 2003 Jan; 147(4):157-9. PubMed ID: 12635547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein EBethesda: a new variant of apolipoprotein E associated with type III hyperlipoproteinemia.
    Gregg RE; Ghiselli G; Brewer HB
    J Clin Endocrinol Metab; 1983 Nov; 57(5):969-74. PubMed ID: 6578216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein epsilon 2/3 genotype and type III hyperlipoproteinemia among Taiwanese.
    Lin HP; Kao JT
    Clin Chim Acta; 2003 Apr; 330(1-2):173-8. PubMed ID: 12636937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type III hyperlipoproteinemia associated with apolipoprotein E deficiency.
    Ghiselli G; Schaefer EJ; Gascon P; Breser HB
    Science; 1981 Dec; 214(4526):1239-41. PubMed ID: 6795720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of bezafibrate and micronised fenofibrate in patients with type III hyperlipoproteinemia.
    Feussner G; Kurth B; Lohrmann J
    Eur J Med Res; 1997 Apr; 2(4):165-8. PubMed ID: 9110923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis.
    Attman PO; Alaupovic P
    Nephron; 1991; 57(4):401-10. PubMed ID: 2046821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Severe type III hyperlipoproteinemia with unusual lipoprotein phenotype in an adolescent patient].
    Ziemer A; Göring HD
    Hautarzt; 1993 Aug; 44(8):538-44. PubMed ID: 8376110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III).
    Utermann G
    Ric Clin Lab; 1982; 12(1):23-30. PubMed ID: 6283616
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hyperlipoproteinemia type III with apolipoprotein E phenotype 2/2].
    Engst R
    Hautarzt; 1985 Nov; 36(11):629-34. PubMed ID: 4077508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the hypolipidemic effect of gemfibrozil versus simvastatin in patients with type III hyperlipoproteinemia.
    Civeira F; Cenarro A; Ferrando J; Puzo J; Garcia-Otín AL; Mozas P; Pocoví M
    Am Heart J; 1999 Jul; 138(1 Pt 1):156-62. PubMed ID: 10385780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels.
    de Knijff P; van den Maagdenberg AM; Frants RR; Havekes LM
    Hum Mutat; 1994; 4(3):178-94. PubMed ID: 7833947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.